FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a compound with anti-tuberculosis activity - dimephosphone isonicotinoylhydrazone of formula I to be applied in medicine and veterinary science.
.
EFFECT: what is offered is a new biologically active compound possessing high anti-tuberculosis activity (MIC=10 mcg/ml), low toxicity (2005±59,6 mg/kg) and manifesting no signs of neurotoxic action.
2 cl, 2 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIMEPHOSPHONE NICOTINOYLHYDRAZONE POSSESSING ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2471787C1 |
| DIALKYL(2-METHYL-4-OXOPENT-2-YL)PHOSPHINE OXIDE PYRIDINOYL HYDRAZONES, HAVING ANTITUBERCULOUS ACTIVITY | 2012 |
|
RU2498990C1 |
| TRAIZINES HAVING ANTI-TUBERCULOSIS ACTIVITY | 2010 |
|
RU2431633C1 |
| ANTITUBERCULAR AGENT BASED ON A PYRIDOXINE DERIVATIVE | 2021 |
|
RU2772219C1 |
| ANTI-TUBERCULOSIS DRUG BASED ON (Z)-3-(3,3-DIMETHYL-2-OXOBUTYLIDENE) -3,4-DIHYDRO-2H-1,4-BENZOXAZIN-2-ONE AND A METHOD FOR ITS SYNTHESIS | 2020 |
|
RU2748748C1 |
| METHOD FOR ESTIMATING ANTIMYCOBACTERIAL ACTION OF ANTI-TUBERCULOSIS DRUGS USING BIOLOGICAL MATERIAL OF PATIENTS WITH PULMONARY TUBERCULOSIS | 2017 |
|
RU2677972C1 |
| METHOD OF DETERMINING DRUG SUSCEPTIBILITY OF TUBERCULOSIS MYCOBACTERIA | 2003 |
|
RU2255977C1 |
| CULTURE MEDIUM FOR DETERMINING DRUG SUSCEPTIBILITY OF M tuberculosis TO MAIN ANTI-TUBERCULOSIS DRUGS | 2010 |
|
RU2470071C2 |
| ANTI-TUBERCULOSIS AGENT BASED ON 4-((HET)AROYL)-3-HYDROXY-1-(2-HYDROXYPHENYL)-5-(PHENYLTHIO)-1,5-DIHYDRO-2H-PYRROL-2-ONES | 2021 |
|
RU2767542C1 |
| ANTITUBERCULOUS COMPOSITE MEDICATION | 2009 |
|
RU2406518C1 |
